Upcoming Events | Past Events | Subscribe (RSS)
The CSIS Global Health Policy Center holds a number of events every year. In addition to our High Level Speaker Series and our Fault Lines in Global Health debates
, we host events with experts from around the world on important current issues in global health. Many of these events will be webcast live, giving you the opportunity to participate from any location and even ask questions of our speakers and panelists beforehand. Your engagement is vital to the continuation of the Global Health Policy Center's work.
If you haven't already, sign up for email updates
to make sure you are aware of all upcoming events, news and publications.
Syria's Assad regime has, with increasing intensity over the past year, systematically targeted medical facilities, staff and patients on an egregious scale with profound human consequences. Armed opposition have also defied the impartiality and neutrality of medical services. Please join us on Friday, May 10, from 2:00-4:00pm at CSIS for a roundtable discussion. Panelists will discuss the trajectory of attacks, the resulting institutional damage and public health implications, evolving efforts by governments, international bodies and NGOs to mitigate these impacts, and prospects in the future for accountability and rehabilitation.
Approximately 1.4 billion people in the world are infected with one or more of the seven most common neglected tropical diseases (NTDs). NTDs have severe public health consequences, including: malnutrition, anemia, serious and permanent disability and disfigurement, illness, and even death. Not only do NTDs disproportionately affect poor and vulnerable populations, the public health consequences of these diseases threaten broader economic and social improvement in affected nations. The countries of Latin America and the Caribbean (LAC) have recognized the threat from NTDs and have begun to unite to work to eliminate a number of these diseases from their region. The LAC countries, supported by multilateral organizations, are working to achieve the elimination of NTDs as a public health threat by 2015 through proven, cost-effective interventions. Please join us for a public discussion that will highlight the progress and prospects for NTD elimination in Latin America and the Caribbean.
The Institute of Medicine’s recently completed Evaluation of PEPFAR assesses the program’s performance over the past decade, as it transitioned from an emergency response to the HIV/AIDS epidemic to an emphasis on strengthening health systems in focal countries. The Evaluation of PEPFAR was a four-year, congressionally mandated review of PEPFAR; it is only the second major review of the program. For this occasion, we have convened representatives from the U.S. administration, evaluation participants, and independent experts to discuss the review’s implications for PEPFAR's policy priorities in the second Obama term.
This event will feature an expert discussion on the findings and recommendations of The Institute of Medicine’s recently released report titled “Countering the Problem of Falsified and Substandard Drugs.” Commissioned by the U.S. Food and Drug Administration, this report raises important, indeed frightening, concerns about the quality and reliability of medicines around the world. The problem of illegitimate drugs has significant and sometimes tragic consequences in the U.S. and other developed nations, as well as in low- and middle-income countries that often have weaker capacities. This event will include a conversation with the lead author of the study, FDA leadership, and representatives from industry and regulatory bodies.
During the first Obama term, global health diplomacy took on elevated importance as a U.S. foreign policy objective. Both the Department of State and the Department of Health and Human Services appear poised to continue to raise the diplomatic profile of global health during the second Obama term. Over the next year, U.S. diplomats will be challenged to help ensure: smooth, sufficient replenishments of the GAVI Alliance, the World Bank International Development Association, and the Global Fund to Fight AIDS, Tuberculosis and Malaria; the articulation of a robust set of goals to advance the post-2015 Millennium Development agenda; and mutually beneficial relationships with emerging powers, many of which are active global health actors.
Over the last decade, the U.S. Navy has substantially enlarged its scheduled, preplanned humanitarian engagement in the Pacific, the Americas, and Africa. After an expansionary period that began with the 2005 response to the Indian Ocean tsunami, intensifying budget pressures are now triggering spirited debate about the true value of these “soft power” missions, which utilize scarce personnel, funding, and assets that otherwise would be dedicated to more traditional and more easily measured and justified “hard power” missions.
In June 2012, to help frame and inform this complex debate, CSIS launched an independent study of U.S. Navy humanitarian assistance, chaired by Admiral Gary Roughead, U.S. Navy (retired). The resulting report, U.S. Navy Humanitarian Assistance in an Era of Austerity, was released at CSIS on Monday, March 11, 2013.
At this session, expert panelists will discuss the opportunities and challenges facing the second Obama administration in moving from policy to implementation on women’s global health issues.
Over the past decade, China and India have emerged as hotbeds of innovation for new biomedical products that have benefitted millions of people throughout the developing world. At this session expert panelists will discuss each nation’s contributions in this area; describe the policy priorities that have set the stage for recent R&D activities; identify barriers to continued R&D expansion; and discuss the optimal mix of incentives and regulations that can stimulate further growth in this sector.
Please join us for a lunchtime launch of our new publication, Global Health as a Bridge to Security, which looks at the intersection of health and security in U.S. foreign policy over the last decade. The keynote will be given by Admiral William Fallon, U.S. Navy (retired), who chaired this effort, followed by a roundtable discussion with Admiral Fallon, Rear Admiral Thomas Cullison, U.S. Navy (retired), Ambassador Cameron Hume, and Dr. Ellen Embrey on the top priority agenda items for future military engagement overseas in public health.
Sir Richard Feachem will speak to the historical patterns of malaria control, the outcomes of accelerated global efforts in the past decade, outstanding challenges, and policy priorities for the next Administration and Congress.
See All Past Events »